SAU:4016
Middle East Pharmaceutical Industries Company · SAU · Healthcare · SAR · FY for 2025
Figures on this page computed 2026-11-08 13:22 UTC
Last close
n/aSAR
Market data
23.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
- Computed from the filing for 2025
22.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
21.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
17.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.15Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
What it pays out is the furthest below its sector's middle: 0.35 against 0.54 on the market's range.
Six questions
lens 5 of 9Six questions
5 yes of 6 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?yes
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?no
pe ratio, read below 20.
5 of 6 questions answered yes; 0 could not be answered.
5 of 6 questions answered yes; 0 could not be answered.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Does it earn money?21.1%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Can it pay what it owes?23.2x
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Is it bigger than five years ago?8.8%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Does the profit turn into cash?17.0%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Is it issuing shares?-22.1%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Is it priced under twenty times earnings?23.4x
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR